• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Preparation and affinity identification of glutamic acid-urea small molecule analogs in prostate cancer.前列腺癌中谷氨酸-尿素小分子类似物的制备及亲和力鉴定
Oncol Lett. 2016 Aug;12(2):1001-1006. doi: 10.3892/ol.2016.4699. Epub 2016 Jun 10.
2
Synthesis and positron emission tomography evaluation of F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer.用于前列腺癌的基于前列腺特异性膜抗原的成像剂F-Glu-Urea-Lys的合成及正电子发射断层扫描评估
Oncol Lett. 2015 Oct;10(4):2299-2302. doi: 10.3892/ol.2015.3625. Epub 2015 Aug 19.
3
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.99mTc 标记的前列腺特异性膜抗原小分子抑制剂用于前列腺癌的分子成像。
J Nucl Med. 2013 Aug;54(8):1369-76. doi: 10.2967/jnumed.112.116624. Epub 2013 Jun 3.
4
Design of a Small-Molecule Drug Conjugate for Prostate Cancer Targeted Theranostics.用于前列腺癌靶向诊疗的小分子药物偶联物设计
Bioconjug Chem. 2016 Jul 20;27(7):1681-9. doi: 10.1021/acs.bioconjchem.6b00222. Epub 2016 Jun 15.
5
Enzymatic radiosynthesis of a F-Glu-Ureido-Lys ligand for the prostate-specific membrane antigen (PSMA).用于前列腺特异性膜抗原(PSMA)的 F-Glu-Ureido-Lys 配体的酶促放射性合成。
Org Biomol Chem. 2019 Feb 6;17(6):1480-1486. doi: 10.1039/c8ob03150a.
6
A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.一系列作为靶向前列腺癌放射性标记探针的前列腺特异性膜抗原(PSMA)卤化异二聚体抑制剂。
J Med Chem. 2009 Jan 22;52(2):347-57. doi: 10.1021/jm800994j.
7
Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen.新型前列腺特异性膜抗原的β-和γ-氨基酸衍生抑制剂。
J Med Chem. 2020 Mar 26;63(6):3261-3273. doi: 10.1021/acs.jmedchem.9b02022. Epub 2020 Mar 9.
8
Synthesis and evaluation of a novel urea-based Ga-complex for imaging PSMA binding in tumor.新型基于尿素的 Ga 配合物的合成与评价及其在 PSMA 结合肿瘤成像中的应用。
Nucl Med Biol. 2018 Apr;59:36-47. doi: 10.1016/j.nucmedbio.2017.12.007. Epub 2017 Dec 27.
9
Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals.基于谷氨酸脲的前列腺特异性膜抗原(PSMA)靶向放射性治疗药物的内化设计
Theranostics. 2016 Apr 28;6(8):1085-95. doi: 10.7150/thno.13448. eCollection 2016.
10
Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer.用于前列腺癌体内分子磁共振成像的靶向前列腺特异性膜抗原的谷氨酸-尿素-赖氨酸支架功能化超顺磁性氧化铁纳米颗粒
Pharmaceutics. 2022 Sep 26;14(10):2051. doi: 10.3390/pharmaceutics14102051.

引用本文的文献

1
Development and clinical potential of F-PSiMA for prostate cancer PET imaging.用于前列腺癌PET成像的F-PSiMA的研发及临床潜力
RSC Med Chem. 2025 May 9. doi: 10.1039/d5md00275c.
2
Novel Selectively Targeted Multifunctional Nanostructured Lipid Carriers for Prostate Cancer Treatment.用于前列腺癌治疗的新型选择性靶向多功能纳米结构脂质载体
Pharmaceutics. 2021 Dec 30;14(1):88. doi: 10.3390/pharmaceutics14010088.
3
Novel and Efficient Method for Solid Phase Synthesis of Urea-Containing Peptides Targeting Prostate Specific Membrane Antigen (PSMA) in Comparison with Current Methods.与现有方法相比,用于固相合成靶向前列腺特异性膜抗原(PSMA)的含尿素肽的新型高效方法。
Iran J Pharm Res. 2018 Summer;17(3):917-926.

本文引用的文献

1
Prostate cancer, version 1.2014.前列腺癌临床实践指南(2014 年版)
J Natl Compr Canc Netw. 2013 Dec 1;11(12):1471-9. doi: 10.6004/jnccn.2013.0174.
2
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.前列腺癌抗原 3 在前列腺癌管理中的当代作用。
Eur Urol. 2011 Nov;60(5):1045-54. doi: 10.1016/j.eururo.2011.08.003. Epub 2011 Aug 25.
3
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
4
Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.良性前列腺上皮中有无前列腺癌男性的差异基因表达:前列腺癌场效应的证据。
Clin Cancer Res. 2010 Nov 15;16(22):5414-23. doi: 10.1158/1078-0432.CCR-10-0272. Epub 2010 Oct 8.
5
Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies.新型选择性血管内皮生长因子受体-2 抑制剂 YN968D1 在晚期恶性肿瘤患者中的安全性和药代动力学。
BMC Cancer. 2010 Oct 5;10:529. doi: 10.1186/1471-2407-10-529.
6
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.胆碱正电子发射断层扫描/计算机断层扫描在前列腺癌根治治疗后前列腺特异性抗原进展患者管理中的作用。
Eur Urol. 2011 Jan;59(1):51-60. doi: 10.1016/j.eururo.2010.09.004. Epub 2010 Sep 15.
7
PET/CT in cancer research: from preclinical to clinical applications.正电子发射断层扫描/计算机断层扫描(PET/CT)在癌症研究中的应用:从临床前到临床。
Contrast Media Mol Imaging. 2010 Jul-Aug;5(4):190-200. doi: 10.1002/cmmi.368.
8
A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules.抗体募集小分子揭示前列腺特异性膜抗原上的远程缝隙结合位点。
J Am Chem Soc. 2010 Sep 15;132(36):12711-6. doi: 10.1021/ja104591m.
9
[Advances in prostate-specific membrane antigen targeted therapies for prostate cancer].[前列腺癌前列腺特异性膜抗原靶向治疗的进展]
Zhonghua Nan Ke Xue. 2010 Jun;16(6):547-51.
10
FDG PET/CT in oncology: "raising the bar".FDG PET/CT 在肿瘤学中的应用:“提高标准”。
Clin Radiol. 2010 Jul;65(7):522-35. doi: 10.1016/j.crad.2010.01.003. Epub 2010 Mar 4.

前列腺癌中谷氨酸-尿素小分子类似物的制备及亲和力鉴定

Preparation and affinity identification of glutamic acid-urea small molecule analogs in prostate cancer.

作者信息

Zhang Zhiwei, Zhu Zheng, Yang Deyong, Fan Weiwei, Wang Jianbo, Li Xiancheng, Chen Xiaochi, Wang Qifeng, Song Xishuang

机构信息

Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.

Department of Urology, Dalian Medical University, Dalian, Liaoning 116085, P.R. China.

出版信息

Oncol Lett. 2016 Aug;12(2):1001-1006. doi: 10.3892/ol.2016.4699. Epub 2016 Jun 10.

DOI:10.3892/ol.2016.4699
PMID:27446384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4950707/
Abstract

In recent years, study concerning activity inhibitors of prostate-specific membrane antigen (PSMA) has been concentrated on the glutamic urea (Glu-urea-R) small molecule and its analogs. The present study aimed to synthesize 4 analogs of Glu-urea-R and identify the affinities of these compounds to PSMA. The compounds were synthesized from raw materials, and the experimental procedures of the present study were in accordance with standard techniques under anhydrous and anaerobic conditions. Glu-urea-Lysine (Glu-urea-Lys), Glu-urea-Ornithine (Glu-urea-Orn), Glu-urea-Glutamine (Glu-urea-Gln) and Glu-urea-Asparagine (Glu-urea-Asn) were successfully synthesized, and their structures were confirmed to be as desired using nuclear magnetic resonance spectroscopy and mass spectrometry. An affinity assay was performed to detect the affinity between the various compounds and PSMA expressed from the prostate cancer LNCap cell line. Glu-urea-Gln had the highest affinity to PSMA, followed by Glu-urea-Asn, Glu-urea-Orn and Glu-urea-Lys. In conclusion, the present study demonstrated that Glu-urea-R specifically binds PSMA expressed in the LNCap cell line and inhibits its activity.

摘要

近年来,关于前列腺特异性膜抗原(PSMA)活性抑制剂的研究主要集中在谷氨酸尿素(Glu-urea-R)小分子及其类似物上。本研究旨在合成4种Glu-urea-R类似物,并确定这些化合物与PSMA的亲和力。化合物由原料合成,本研究的实验步骤符合无水和无氧条件下的标准技术。成功合成了谷氨酸尿素-赖氨酸(Glu-urea-Lys)、谷氨酸尿素-鸟氨酸(Glu-urea-Orn)、谷氨酸尿素-谷氨酰胺(Glu-urea-Gln)和谷氨酸尿素-天冬酰胺(Glu-urea-Asn),并使用核磁共振光谱和质谱确认其结构符合预期。进行亲和力测定以检测各种化合物与前列腺癌LNCap细胞系表达的PSMA之间的亲和力。Glu-urea-Gln对PSMA的亲和力最高,其次是Glu-urea-Asn、Glu-urea-Orn和Glu-urea-Lys。总之,本研究表明Glu-urea-R特异性结合LNCap细胞系中表达的PSMA并抑制其活性。